Stephen A. D'Amato, PharmD, MS

All articles by Stephen A. D'Amato, PharmD, MS

February 8, 2016

Preoperative ultrasound characteristics of papillary thyroid carcinoma (PTC) associated with extranodal extension (ENE) have been identified.

February 5, 2016

Patient age and tumor risk may be more strongly associated with use of expectant management for veterans with low-risk prostate cancer.

January 27, 2016

Afatinib may demonstrate clinical activity in patients with EGFR mutation-positive non-small cell lung cancer (NSCLC) and brain metastasis.

October 1, 2014

Over the past decade, there has been significant progress in the development of novel cancer therapies.

April 9, 2013

This class of biotherapeutics has the potential to effectively target a variety of cancers, with fewer toxic side effects for the patient.

January 4, 2013

New oral drugs are being introduced to the fight against cancer; with them come unique questions involving cost, insurance, and policy.

October 4, 2012

Identifying the factors that contribute to patients’ and physicians’ hesitancy about cancer clinical trials can help improve participation.

Next post in General Oncology